How can altering DNA help defeat one of the world’s deadliest diseases? This video explores how scientists are using CRISPR ...

Both CRSP and NTLA are advancing in vivo gene editing therapies targeting large markets, with financial stability supporting ...

Lateone monsoon evening in Tiruppur, a textile buyer ran two fingers across a swatch he couldn’t quite place. It felt like ...

Cells contain a blueprint in the form of DNA that dictates what they can make. This blueprint is converted into a message ...

The $12.5 billion acquisition of Avidity Biosciences Inc. by Novartis AG strengthens the company’s neuroscience pipeline and marks the second biggest deal that’s been announced this year. San ...

In cities, coworking spaces bring people together to collaborate and innovate. Inside cancer cells, a similar concept plays out -- but with deadly ...

Overview of Epigenetics MarketThe global Epigenetics Market is valued at USD 2.56 Billion in 2024 and is projected to reach a value of USD 9.11 Billion by 2035 at a CAGR (Compound Annual Growth Rate) ...

Sometimes the biggest moments at a conference happen backstage. At the annual STAT Summit, that kind of moment involved a ...

Return on Assets (ROA): Regeneron Pharmaceuticals's financial strength is reflected in its exceptional ROA, which exceeds industry averages. With a remarkable ROA of 3.67%, the company showcases ...

Cells process dynamic signaling inputs to regulate fate decisions during development. While oscillations or waves in key developmental pathways, such as Wnt, have been widely observed, the principles ...

Takeda Pharmaceutical Company Limited ( NYSE: TAK) Discusses Global Strategic Collaboration for Next-Generation Oncology Assets and ADC Molecules October 22, 2025 9:00 AM EDT ...